ZuoYi Technology, a leading domestic medical artificial intelligence system development company, recently announced the successful closing of a RMB 100 million Series B financing. The round was led by Qiming Venture Partners, with participation from well-
New SORL successfully closes a RMB 500 million Series A financing. The round was led by HengXu Capital, with participation from SPIC, AutoCapital, Ruijian Capital, as well as local state-owned enterprises like Wenzhou Transportation Group and upstream sup
Wenheyou successfully closed a significant Series B financing with investment from HongShan, IDG Capital, Warburg Pincus, Country Garden Venture Capital, GIC, and CEC Fund, amongst others. CEC Capital Group served as the exclusive financial advisor fo
Berry Oncology recently announced the successful raising of nearly RMB 700 million in its Series B1 financing, led by China Merchants Capital, with support from existing shareholders Qiming Venture Partners and Legend Capital. Other investment institution
M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.
M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.
Huihe Healthcare, a global leading structural heart disease platform company, successfully completed its B round financing of several hundred of million of RMB. This financing was led by IDG Capital, with participation from existing shareholders Growth Ca
Chinese tea brand "CHALI" successfully completed a new round of financing of several hundred million RMB. The funding was led by GGV Capital, with continued investment from B-round lead investor Country Garden Venture Capital, as well as participation fro
closing of a RMB 200 million Series B+ financing round. The funding was led by Qiming Venture Partners, with participation from BioVenture, C&D Emerging Industry Investment, and existing shareholder Sino-Ocean Capital. CEC Capital Group acted as the e